Greenply Industries ranked 413 on the Fortune India 500, is the largest producer of plywood and medium-density fibre (MDF) in the country. The Indian plywood and panel market is estimated at Rs 15,000 crore, with organised players accounting for a mere Rs 4,500 crore. Seen here is Greenply’s MDF plant at Pantnagar, Uttarakhand. Like other Asian producers, the company has been hit hard by the Myanmar government’s decision to stop teak exports. (Myanmar is the leading source of raw material for much of the plywood industry.) To add to its challenges, the BJP government’s focus on building new urban infrastructure in India has augmented already high domestic demand. In response, Greenply is pushing its timber plantation-cum-agroforestry model as a long-term, sustainable solution that eliminates much of the uncertainty of the timber business. Its strategy to reduce dependence on imports, coupled with an improvement in the overall economy, has seen its stock price double to Rs 800 levels last year.
Top Stories
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.